The efficacy and safety characteristics of long-term pregabalin treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: Findings from an open-label trial

被引：0
|
作者：
D'Urso-De Cruz, E
Dworkin, R
Stacey, B
Siffert, J
Fukui, A
Emir, B
机构：
[1] Pfizer Inc, Pfizer Global Pharmaceut, New York, NY USA
[2] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY USA
[3] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA
[4] Pfizer Australia, Pfizer Global Pharmaceut, Sydney, NSW, Australia
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [21] Effects of pregabalin on pain and nerve conduction in patients with painful diabetic peripheral neuropathy (DPN): a 13-week randomized controlled trial and 6-month open-label safety extension
    Arezzo, J.
    Rosenstock, J.
    LaMoreaux, L.
    Pauer, L.
    Sharma, U.
    DIABETOLOGIA, 2007, 50 : S471 - S471
  • [22] A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy
    Simpson, David M.
    Rice, Andrew S. C.
    Emir, Birol
    Landen, Jaren
    Semel, David
    Chew, Marci L.
    Sporn, Jonathan
    PAIN, 2014, 155 (10) : 1943 - 1954
  • [23] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [24] Effect of duloxetine 60 mg once daily in patients with diabetic peripheral neuropathic pain in long-term open-label study
    Skljarevski, V.
    Desaiah, D.
    Zhang, Q.
    Chappell, A. S.
    Detke, M. J.
    Gross, J. L.
    DIABETOLOGIA, 2008, 51 : S503 - S504
  • [25] Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial
    Kato, Jitsu
    Matsui, Norimitsu
    Kakehi, Yoshihiro
    Murayama, Emiko
    Ohwada, Shoichi
    MEDICINE, 2020, 99 (36) : E21976
  • [26] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (04): : 653 - 661
  • [27] Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial
    Beck, L. A.
    Mette, D.
    Zhang, Q.
    Akinlade, B.
    Staudinger, H.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S43 - S43
  • [28] A long-term open-label trial of safety and efficacy of Sativex®, a cannabis based medicine, in central neuropathic pain due to multiple sclerosis
    Rog, D. J.
    Nurmikko, T. J.
    Sarantis, N. S.
    Young, C. A.
    JOURNAL OF NEUROLOGY, 2006, 253 : 100 - 100
  • [29] Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an open-label, Extension Trial
    Halford, Jonathan
    Scheffer, Ingrid
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Malawsky, Yael Shiloh
    Wong, Matthew
    Checketts, Daniel
    VanLandingham, Kevan
    NEUROLOGY, 2019, 92 (15)
  • [30] Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic PolyneuropathyInterim Analysis from an Open-Label, Two-Stage Adaptive, Randomized, Controlled Trial
    Ralf Baron
    Victor Mayoral
    Göran Leijon
    Andreas Binder
    Ilona Steigerwald
    Michael Serpell
    Clinical Drug Investigation, 2009, 29 : 231 - 241
12345